review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1102/1470-7330.2006.0014 |
P8608 | Fatcat ID | release_qu322oiugfejtjl2aajihkf7se |
P932 | PMC publication ID | 1693764 |
P698 | PubMed publication ID | 16829469 |
P5875 | ResearchGate publication ID | 6956862 |
P2093 | author name string | Silverman PM | |
Szklaruk J | |||
Bhosale P | |||
P2860 | cites work | Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma | Q33367527 |
Role of computerized tomography in the staging of gastrointestinal neoplasms | Q34277268 | ||
Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma | Q35064510 | ||
Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. | Q35621307 | ||
Histopathology of liver cancers | Q36066442 | ||
Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care | Q36157626 | ||
The continuing challenge of hepatic cancer in Asia | Q36216695 | ||
Percutaneous image-guided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma | Q36245060 | ||
Staging and current treatment of hepatocellular carcinoma | Q36287663 | ||
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation | Q46591334 | ||
Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). | Q46755959 | ||
Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma | Q47370771 | ||
Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? | Q53673529 | ||
Extrahepatic Metastases of Hepatocellular Carcinoma | Q56172243 | ||
Hepatocellular Carcinoma: Role of Unenhanced and Delayed Phase Multi–Detector Row Helical CT in Patients with Cirrhosis | Q57944384 | ||
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma | Q60198990 | ||
Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS) | Q74072038 | ||
Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations | Q81124737 | ||
[Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma] | Q81270067 | ||
[Epidemiology, natural history and pathogenesis of hepatocellular carcinoma] | Q81355294 | ||
Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection | Q81432249 | ||
Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging | Q82625559 | ||
P921 | main subject | hepatocellular carcinoma | Q1148337 |
liver neoplasm | Q18558073 | ||
P304 | page(s) | 83-94 | |
P577 | publication date | 2006-07-04 | |
P1433 | published in | Cancer Imaging | Q2577267 |
P1476 | title | Current staging of hepatocellular carcinoma: imaging implications | |
P478 | volume | 6 |
Q35621289 | Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis |
Q89377149 | Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis |
Q28084003 | Guide for diagnosis and treatment of hepatocellular carcinoma |
Search more.